BIO.WA
Bioton SA
Price:  
3.82 
PLN
Volume:  
55,384.00
Poland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BIO.WA WACC - Weighted Average Cost of Capital

The WACC of Bioton SA (BIO.WA) is 10.1%.

The Cost of Equity of Bioton SA (BIO.WA) is 10.95%.
The Cost of Debt of Bioton SA (BIO.WA) is 6.65%.

Range Selected
Cost of equity 9.80% - 12.10% 10.95%
Tax rate 19.00% - 19.00% 19.00%
Cost of debt 6.30% - 7.00% 6.65%
WACC 9.1% - 11.1% 10.1%
WACC

BIO.WA WACC calculation

Category Low High
Long-term bond rate 5.5% 6.0%
Equity market risk premium 6.3% 7.3%
Adjusted beta 0.68 0.76
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.80% 12.10%
Tax rate 19.00% 19.00%
Debt/Equity ratio 0.17 0.17
Cost of debt 6.30% 7.00%
After-tax WACC 9.1% 11.1%
Selected WACC 10.1%

BIO.WA's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for BIO.WA:

cost_of_equity (10.95%) = risk_free_rate (5.75%) + equity_risk_premium (6.80%) * adjusted_beta (0.68) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.